Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsu.edu.ru/handle/123456789/19816
Title: Cardiovascular effects of an arginase II selective inhibitor
Authors: Yakushev, V. I.
Pokrovskii, M. V.
Keywords: medicine
pharmacology
arginase II selective inhibitors
ZB49-0010C
L-NAME
endothelial dysfunction
nitric oxide
methionine
homocysteine
ischemia
cardioprotective effect
Issue Date: 2016
Citation: Yakushev, V.I.  Cardiovascular effects of an arginase II selective inhibitor / V. I. Yakushev, M. V. Pokrovskii // Research result: pharmacology and clinical pharmacology. - 2016. - Vol.2, №3.- P. 28-45. - DOI: 10.18413/2500-235X -2016-2-3-28-45. - Refer.: p. 43-45.
Abstract: For the first time in vitro experiments there were studied the inhibitory activity and safety of potential molecules arginase II selective inhibitors from the group of norleucine derivatives. Also first the substance under the code ZB49-0010C from the group of norleucine derivatives showed the greatest selectivity and inhibitory activity against arginase II in experiments in vitro. However, this substance in vivo exerts dose-dependent hypotensive action and cardioprotective and endothelial protective effects on the L-NAME induced and homocysteine-induced endothelial dysfunction (ED), which are most pronounced at a dose of 10 mg/kg in intragastric administration
URI: http://dspace.bsu.edu.ru/handle/123456789/19816
Appears in Collections:Research Result. Pharmacology and Clinical Pharmacology

Files in This Item:
File Description SizeFormat 
Yakushev_Cardiovascula_16.pdf2.37 MBAdobe PDFView/Open
Show full item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.